Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cardiovascular Innovations and Applications is Scopus-indexed (Q3, CiteScore 2.6), WoS ESCI, DOAJ. Published by Compuscript Ltd.
Checked against the index lists dated .
ISSN 2009-8618Verify ISSN ↗2009-8782Verify ISSN ↗
Publisher: Compuscript Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 220 / 409 | 46th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q3, CiteScore 2.6.
Cardiovascular Innovations and Applications is Q3 in Cardiology and Cardiovascular Medicine (rank 220 of 409), by CiteScore 2025.
Cardiovascular Innovations and Applications is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.6, which places it in quartile Q3 at the 46th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.526, quartile Q2, with an H-index of 10.
Cardiovascular Innovations and Applications is published by Compuscript Ltd. Its print ISSN is 2009-8618 and its online ISSN is 2009-8782.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Cardiovascular Innovations and Applications has an h-index of 12 and a 2-year mean of 1.69 citations per paper (OpenAlex). Its Scopus CiteScore is 2.6, quartile Q3. On 2-year citations it ranks #158 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Cardiovascular Innovations and Applications published 46 papers in 2025; its busiest recent year was 2023 with 80. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 78 research articles (2024–2026), authors are most often from China (61.3%), United States (8.5%) and Italy (3.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.